Sirolimus and prostate cancer Patient Reports February 11, 2012

Sirolimus Side Effects Report #5227098-5
Sirolimus side effect was reported by a Physician from SPAIN on Jan 23, 2007. Male patient, weighting 168.7 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, hypercholesterolaemia, intermittent claudication and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: unknown. During the same period patient was treated with AMLODIPINE, PREDNISONE, DOXAZOSIN MESYLATE, ATORVASTATIN CALCIUM, MYCOPHENOLATE MOFETIL, LOSARTAN POTASSIUM. Patient recovered.

Sirolimus Side Effects Report #5246721-2
Sirolimus side effect was reported by a Physician from SPAIN on Feb 16, 2007. Male patient, weighting 168.7 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, hypercholesterolaemia, intermittent claudication and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: unknown. During the same period patient was treated with AMLODIPINE, PREDNISONE, DOXAZOSIN MESYLATE, ATORVASTATIN, MYCOPHENOLATE MOFETIL, LOSARTAN POTASSIUM. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5327819-7
Sirolimus side effect was reported by a Physician from SPAIN on May 14, 2007. Male patient, weighting 174.2 lb, was diagnosed with prophylaxis against transplant rejection, prostatism, hyperuricaemia and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: 2 MG/FREQUENCY NOT PROVIDED. During the same period patient was treated with INDAPAMIDE, TEBETANE COMPUESTO, ALLOPURINOL. Patient recovered.

Sirolimus Side Effects Report #5340244-8
Sirolimus side effect was reported by a Physician from SPAIN on May 22, 2007. Male patient, weighting 168.7 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, hypercholesterolaemia, intermittent claudication and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: unknown. During the same period patient was treated with AMLODIPINE, PREDNISONE, DOXAZOSIN MESYLATE, ATORVASTATIN, MYCOPHENOLATE MOFETIL, LOSARTAN POSTASSIUM. Patient was hospitalized. Patient recovered.


Sirolimus Side Effects Report #5350503-0
Sirolimus side effect was reported by a Physician from SPAIN on June 01, 2007. Male patient, weighting 168.7 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, hypercholesterolaemia, intermittent claudication and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: unknown. During the same period patient was treated with AMLODIPINE, PREDNISONE, DOXAZOSIN MESYLATE, ATORVASTATIN, MYCOPHENOLATE MOFETIL, LOSARTAN POTASSIUM. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5488529-9
Sirolimus side effect was reported by a Physician from SPAIN on Oct 15, 2007. Male patient, weighting 174.2 lb, was diagnosed with prophylaxis against transplant rejection, prostatism, hyperuricaemia and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: 2 MG/FREQUENCY NOT PROVIDED. During the same period patient was treated with INDAPAMIDE, TEBETANE COMPUESTO, ALLOPURINOL. Patient recovered.

Sirolimus Side Effects Report #5719319-7
Sirolimus side effect was reported by a Physician from SPAIN on Apr 23, 2008. Male patient, weighting 165.3 lb, was diagnosed with prophylaxis against transplant rejection, diabetes mellitus, prostatism, hyperuricaemia, hypertension and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: 2 MG/FREQUENCY NOT PROVIDED. During the same period patient was treated with METFORMIN, TEBETANE COMPUESTO, ALLOPURINOL, INDAPAMIDE. Patient recovered.

Sirolimus Side Effects Report #5732161-6
Sirolimus side effect was reported by a Physician from CANADA on May 07, 2008. Male patient, weighting 141.8 lb, was diagnosed with prophylaxis against transplant rejection, lipids increased, hypertension and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: unknown. During the same period patient was treated with PRAVASTATIN, RAMIPRIL. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5828409-X
Sirolimus side effect was reported by a Physician from SPAIN on July 29, 2008. Male patient, weighting 165.3 lb, was diagnosed with prophylaxis against transplant rejection, prostatism, diabetes mellitus, hyperuricaemia, hypertension and was treated with Sirolimus. After drug was administered, patient experienced the following side effects: prostate cancer . Sirolimus dosage: 2 MG/FREQUENCY NOT PROVIDED. During the same period patient was treated with BOI K, TEBETANE COMPUESTO, METFORMIN, ALLOPURINOL, INDAPAMIDE. Patient recovered.